Cargando…

Iron-based phosphate binders: do they offer advantages over currently available phosphate binders?

Increased cardiovascular morbidity and mortality has been associated with the hyperphosphatemia seen in patients with end-stage chronic kidney disease (CKD). Oral phosphate binders are prescribed in these patients to prevent intestinal absorption of dietary phosphate and reduce serum phosphate. In p...

Descripción completa

Detalles Bibliográficos
Autores principales: Negri, Armando Luis, Ureña Torres, Pablo Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370297/
https://www.ncbi.nlm.nih.gov/pubmed/25815172
http://dx.doi.org/10.1093/ckj/sfu139